News
Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...
The PD-L1 Inhibitors drugs uptake section examines the rate at which newly launched or upcoming potential drugs are being ...
Researchers at Northeastern University have identified two proteins abundant on drug-resistant ovarian cancer cells that ...
14h
AZoLifeSciences on MSNTUM Scientists Develop Breakthrough Method to Monitor CAR-T CellsIn modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets.
When Cells at Work! hit theaters in Japan, nobody expected it to become one of the year’s biggest cultural surprises.
A new platform comprehensively profiles CAR T-cells during manufacturing, revealing phenotypic shifts. This allows for ...
Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...
16h
ZME Science on MSNCAR T Breakthrough Therapy Doubles Survival Time for Deadly Stomach CancerThe cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...
Inflammation and tumorigenesis are intricately connected processes with significant overlap in their underlying mechanisms. Chronic inflammation is now ...
When you think of dinosaurs, you might imagine towering predators or gentle giants roaming prehistoric landscapes. But what ...
11h
Medpage Today on MSNBTK Inhibitors for Multiple SclerosisMultiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...
Johnson & Johnson’s dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma: Milan Monday, June 16, 2025, 14:00 Hrs [IST] Johnson & Johnson an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results